| Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae J Rodríguez-Baño, B Gutiérrez-Gutiérrez, I Machuca, A Pascual Clinical microbiology reviews 31 (2), 10.1128/cmr. 00079-17, 2018 | 789 | 2018 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 527 | 2017 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 386 | 2020 |
| A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase … B Gutiérrez-Gutiérrez, S Perez-Galera, E Salamanca, M De Cueto, ... Antimicrobial agents and chemotherapy 60 (7), 4159-4169, 2016 | 182 | 2016 |
| Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations JM Aguado, JT Silva, M Fernández-Ruiz, E Cordero, J Fortún, C Gudiol, ... Transplantation Reviews 32 (1), 36-57, 2018 | 146 | 2018 |
| Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and … A Cano, B Gutiérrez-Gutiérrez, I Machuca, I Gracia-Ahufinger, ... Clinical Infectious Diseases 66 (8), 1204-1210, 2018 | 126 | 2018 |
| A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... Mayo Clinic Proceedings 91 (10), 1362-1371, 2016 | 109 | 2016 |
| Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients B Gutiérrez-Gutiérrez, J Rodríguez-Baño Clinical Microbiology and Infection 25 (8), 932-942, 2019 | 107 | 2019 |
| Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial J Molina, E Montero-Mateos, J Praena-Segovia, E León-Jiménez, ... Clinical Microbiology and Infection 28 (4), 550-557, 2022 | 105 | 2022 |
| Mortality associated with bacteremia due to colistin-resistant Klebsiella pneumoniae with high-level meropenem resistance: importance of combination therapy without colistin … I Machuca, B Gutierrez-Gutierrez, I Gracia-Ahufinger, F Rivera Espinar, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00406-17, 2017 | 94 | 2017 |
| Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 86 | 2021 |
| Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial J Sojo-Dorado, I López-Hernández, C Rosso-Fernandez, IM Morales, ... JAMA network open 5 (1), e2137277-e2137277, 2022 | 73 | 2022 |
| Comparison of predictors and mortality between bloodstream infections caused by ESBL-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae O Scheuerman, V Schechner, Y Carmeli, B Gutierrez-Gutierrez, E Calbo, ... infection control & hospital epidemiology 39 (6), 660-667, 2018 | 73 | 2018 |
| Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase … ZR Palacios-Baena, B Gutiérrez-Gutiérrez, M De Cueto, P Viale, ... Journal of Antimicrobial Chemotherapy 72 (3), 906-913, 2017 | 68 | 2017 |
| Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study B Gutierrez-Gutierrez, RA Bonomo, Y Carmeli, DL Paterson, B Almirante, ... Journal of Antimicrobial Chemotherapy 71 (6), 1672-1680, 2016 | 60 | 2016 |
| Empiric therapy with carbapenem-sparing regimens for bloodstream infections due to extended-spectrum β-lactamase–producing enterobacteriaceae: results from the INCREMENT Cohort ZR Palacios-Baena, B Gutiérrez-Gutiérrez, E Calbo, B Almirante, P Viale, ... Clinical Infectious Diseases 65 (10), 1615-1623, 2017 | 56 | 2017 |
| Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing … I Machuca, B Gutiérrez-Gutiérrez, S Perez Cortes, I Gracia-Ahufinger, ... Journal of Antimicrobial Chemotherapy 71 (11), 3242-3249, 2016 | 52 | 2016 |
| Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA) S Pérez-Galera, JM Bravo-Ferrer, M Paniagua, T Kostyanev, ... EClinicalMedicine 57, 2023 | 48 | 2023 |
| Immunoguided discontinuation of prophylaxis for cytomegalovirus disease in kidney transplant recipients treated with antithymocyte globulin: a randomized clinical trial A Páez-Vega, B Gutiérrez-Gutiérrez, ML Agüera, C Facundo, ... Clinical Infectious Diseases 74 (5), 757-765, 2022 | 42 | 2022 |
| Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae A Russo, M Falcone, B Gutiérrez-Gutiérrez, E Calbo, B Almirante, ... International journal of antimicrobial agents 52 (5), 577-585, 2018 | 39 | 2018 |
